Early Lyme disease has long been difficult to diagnose. Standard two‑tier testing often misses infections in the first weeks, when symptoms are vague and antibodies are still developing. A new study suggests that may be changing. IGeneX reports that its FDA‑cleared single‑step... Read More »




























